| Microbial translocation is a cause of systemic immune activation in chronic HIV infection JM Brenchley, DA Price, TW Schacker, TE Asher, G Silvestri, S Rao, ... Nature medicine 12 (12), 1365-1371, 2006 | 4215 | 2006 |
| Effect of early versus deferred antiretroviral therapy for HIV on survival MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ... New England Journal of Medicine 360 (18), 1815-1826, 2009 | 1586 | 2009 |
| Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection W Jiang, MM Lederman, P Hunt, SF Sieg, K Haley, B Rodriguez, ... Journal of Infectious Diseases 199 (8), 1177-1185, 2009 | 740 | 2009 |
| Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment AR Tenorio, Y Zheng, RJ Bosch, S Krishnan, B Rodriguez, PW Hunt, ... Journal of Infectious Diseases 210 (8), 1248-1259, 2014 | 607 | 2014 |
| Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America MJ Silverberg, B Lau, AC Justice, E Engels, MJ Gill, JJ Goedert, GD Kirk, ... Clinical infectious diseases 54 (7), 1026-1034, 2012 | 587 | 2012 |
| Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection PW Hunt, E Sinclair, B Rodriguez, C Shive, B Clagett, N Funderburg, ... Journal of Infectious Diseases, jiu238, 2014 | 512 | 2014 |
| Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment CF Kelley, CMR Kitchen, PW Hunt, B Rodriguez, FM Hecht, M Kitahata, ... Clinical Infectious Diseases 48 (6), 787-794, 2009 | 493 | 2009 |
| Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 MM Lederman, RS Veazey, R Offord, DE Mosier, J Dufour, M Mefford, ... Science 306 (5695), 485-487, 2004 | 483 | 2004 |
| Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance CM Marra, Y Zhao, DB Clifford, S Letendre, S Evans, K Henry, RJ Ellis, ... AIDS (London, England) 23 (11), 1359, 2009 | 437 | 2009 |
| Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection B Rodríguez, AK Sethi, VK Cheruvu, W Mackay, RJ Bosch, M Kitahata, ... Jama 296 (12), 1498-1506, 2006 | 432 | 2006 |
| Perforin expression directly ex vivo by HIV-specific CD8+ T-cells is a correlate of HIV elite control AR Hersperger, F Pereyra, M Nason, K Demers, P Sheth, LY Shin, ... PLoS pathogens 6 (5), e1000917, 2010 | 407 | 2010 |
| Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy PW Hunt, SG Deeks, B Rodriguez, H Valdez, SB Shade, DI Abrams, ... Aids 17 (13), 1907-1915, 2003 | 352 | 2003 |
| Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells MM Lederman, L Calabrese, NT Funderburg, B Clagett, K Medvik, ... Journal of Infectious Diseases 204 (8), 1217-1226, 2011 | 350 | 2011 |
| Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation NT Funderburg, E Mayne, SF Sieg, R Asaad, W Jiang, M Kalinowska, ... Blood 115 (2), 161-167, 2010 | 336 | 2010 |
| Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384 GK Robbins, JG Spritzler, ES Chan, DM Asmuth, RT Gandhi, ... Clinical Infectious Diseases 48 (3), 350-361, 2009 | 295 | 2009 |
| Late presentation for human immunodeficiency virus care in the United States and Canada KN Althoff, SJ Gange, MB Klein, JT Brooks, RS Hogg, RJ Bosch, ... Clinical infectious diseases 50 (11), 1512-1520, 2010 | 282 | 2010 |
| Cohort profile: The Centers for AIDS research Network of Integrated clinical systems MM Kitahata, B Rodriguez, R Haubrich, S Boswell, WC Mathews, ... International journal of epidemiology 37 (5), 948-955, 2008 | 276 | 2008 |
| Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome NT Funderburg, DA Zidar, C Shive, A Lioi, J Mudd, LW Musselwhite, ... Blood 120 (23), 4599-4608, 2012 | 242 | 2012 |
| Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized … Y Levy, I Sereti, G Tambussi, JP Routy, JD Lelievre, JF Delfraissy, ... Clinical infectious diseases 55 (2), 291-300, 2012 | 240 | 2012 |
| HIV type 1 chemokine co-receptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.(vol 44, pg … TJ Wilkin, Z Su, DR Kuritzkes, M Hughes, C Flexner, R Gross, E Coakley, ... CLINICAL INFECTIOUS DISEASES 44 (10), 1399-1399, 2007 | 238 | 2007 |
